您当前的位置：

Ibandronic acid-d3

目录号: PL14467

Ibandronic acid-d3 是 Ibandronic acid 的氘代物。Ibandronic acid是高效含氮双磷酸盐，可作用于骨质疏松。

CAS No. :1130899-41-0

商品编号	规格	价格	会员价
PL14467-2.5mg	2.5mg	询价	询价
PL14467-5mg	5mg	询价	询价
PL14467-25mg	25mg	询价	询价

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

*注意事项:下单时请联系销售核实产品价格及货期，避免后续产生不便，感谢支持!

加入购物车在线咨询收藏产品大包装询价

中文名称	Ibandronic acid-d3
中文别名	[ 2H3 ] - 伊班膦酸标准品;伊班膦酸-D3
英文名称	Ibandronic acid-d3
英文别名	Ibandronic Acid-d3;[1-hydroxy-3-[pentyl(trideuteriomethyl)amino]-1-phosphonopropyl]phosphonic acid
Cas No.	1130899-41-0
分子式	C₉H₂₃NO₇P₂
分子量	319.23
包装储存	Please store the product under the recommended conditions in the Certificate of Analysis.
详情描述	Ibandronic acid-d3 是 Ibandronic acid 的氘代物。Ibandronic acid是高效含氮双磷酸盐，可作用于骨质疏松。

产品详情	Ibandronic acid-d₃ 是 Ibandronic acid 的氘代物。Ibandronic acid是高效含氮双磷酸盐，可作用于骨质疏松。
生物活性	Ibandronic acid-d 3 is the deuterium labeled Ibandronic acid. Ibandronic acid is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis.
体外研究(In Vitro)	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78(3): p. 453-8.

搜索质检报告(COA)

产品使用指南

Data Sheet

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
[2]. Morgan, C., S. Jeremiah, and J. Wagstaff, Metronomic administration of ibandronate and its anti-angiogenic effects in vitro. Microvasc Res, 2009. 78(3): p. 453-8.

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

Ibandronic acid-d3

相关产品

The molarity calculator equation

The dilution calculator equation